why choose us

First received: February 10, 2025

Clinical Trial: A Randomized, Safety and Efficacy Study of Taneasy 600mg Granules and Fluimucil 600mg Granules in COPD Subjects

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: COPD (Chronic Obstructive Pulmonary Disease)

Study Type: INTERVENTIONAL


Official Title: A Randomized, Safety and Efficacy Study of Taneasy 600mg Granules and Fluimucil 600mg Granules in COPD Subjects

Brief Summary: To evaluate the safety and efficacy of Taneasy 600mg granules and Fluimucil 600mg granules administered twice daily for 14 days in treatment of COPD Disease.

Read more